Nuformix PLC
LSE:NFX

Watchlist Manager
Nuformix PLC Logo
Nuformix PLC
LSE:NFX
Watchlist
Price: 0.295 GBX 15.69% Market Closed
Market Cap: 6.2m GBX

Net Margin
Nuformix PLC

0%
Current
-317%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-3.8m
/
Revenue
0

Net Margin Across Competitors

Country Company Market Cap Net
Margin
UK
Nuformix PLC
LSE:NFX
6.2m GBP N/A
US
Eli Lilly and Co
NYSE:LLY
978.2B USD
31%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
485.6B USD
27%
CH
Roche Holding AG
SIX:ROG
257.9B CHF
15%
UK
AstraZeneca PLC
LSE:AZN
206.8B GBP
16%
US
Merck & Co Inc
NYSE:MRK
265B USD
30%
CH
Novartis AG
SIX:NOVN
207.5B CHF
26%
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK
33%
IE
Endo International PLC
LSE:0Y5F
213.9B USD
-126%
US
Pfizer Inc
NYSE:PFE
142.8B USD
16%
No Stocks Found

Nuformix PLC
Glance View

Market Cap
6.2m GBX
Industry
Pharmaceuticals

Nuformix Plc is a pharmaceutical development company, which targets unmet medical needs in fibrosis and oncology via drug repurposing. The company is headquartered in Cambridge, Cambridgeshire and currently employs 3 full-time employees. The company went IPO on 2015-12-17. The firm focuses on medical needs in fibrosis and oncology using drug repurposing. Its clinical pipeline includes NXP001, NXP002 and NXP004. NXP001, is a form of the drug aprepitant that is marketed as a product in the oncology supportive care setting (chemotherapy induced nausea and vomiting). NXP002, is its pre-clinical lead asset and used for inhaled treatment for idiopathic pulmonary fibrosis (IPF). NXP004, is an oncology drug that is used for the treatment of several cancers. The firm's subsidiary is Nuformix Technologies Limited.

NFX Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-3.8m
/
Revenue
0
What is the Net Margin of Nuformix PLC?

Based on Nuformix PLC's most recent financial statements, the company has Net Margin of 0%.

Back to Top